Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1503518/000110465916096509/a15-18065_110q.htm
Exhibit 99.1
21ST CENTURY ONCOLOGY HOLDINGS, INC. | |||||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||||||||
(in thousands, except share amounts) | |||||||||||||
(unaudited) | |||||||||||||
|
|
|
PRELIMINARY |
|
ADJUSTMENTS |
|
|
|
FINAL |
| |||
|
|
|
September 30, |
|
September 30, |
|
|
|
September 30, |
| |||
|
|
|
2015 |
|
2015 |
|
|
|
2015 |
| |||
|
|
|
|
|
|
|
|
|
|
| |||
ASSETS | |||||||||||||
|
Current assets: |
|
|
|
|
|
|
|
|
| |||
|
Cash and cash equivalents |
|
$ |
47,793 |
|
$ |
|
|
|
|
$ |
47,793 |
|
|
Restricted cash |
|
80 |
|
|
|
|
|
80 |
| |||
|
Marketable securities |
|
622 |
|
|
|
|
|
622 |
| |||
|
Accounts receivable, net |
|
149,224 |
|
|
|
|
|
149,224 |
| |||
|
Prepaid expenses |
|
9,381 |
|
|
|
|
|
9,381 |
| |||
|
Inventories |
|
5,162 |
|
|
|
|
|
5,162 |
| |||
|
Deferred income taxes |
|
191 |
|
|
|
|
|
191 |
| |||
|
Other |
|
8,056 |
|
|
|
|
|
8,056 |
| |||
|
Total current assets |
|
220,509 |
|
|
|
|
|
220,509 |
| |||
|
|
|
|
|
|
|
|
|
|
| |||
|
Equity investments in joint ventures |
|
1,236 |
|
|
|
|
|
1,236 |
| |||
|
Property and equipment, net |
|
249,392 |
|
|
|
|
|
249,392 |
| |||
|
Real estate subject to finance obligation |
|
11,625 |
|
|
|
|
|
11,625 |
| |||
|
Goodwill |
|
492,084 |
|
|
|
|
|
492,084 |
| |||
|
Intangible assets, net |
|
74,434 |
|
|
|
|
|
74,434 |
| |||
|
Other assets |
|
49,282 |
|
|
|
|
|
49,282 |
| |||
|
Total assets |
|
$ |
1,098,562 |
|
$ |
|
|
|
|
$ |
1,098,562 |
|
|
|
|
|
|
|
|
|
|
|
| |||
LIABILITIES AND EQUITY | |||||||||||||
|
|
|
|
|
|
|
|
|
|
| |||
|
Current liabilities: |
|
|
|
|
|
|
|
|
| |||
|
Accounts payable |
|
$ |
59,397 |
|
$ |
|
|
|
|
$ |
59,397 |
|
|
Accrued expenses |
|
111,084 |
|
28,977 |
|
A |
|
140,061 |
| |||
|
Income taxes payable |
|
1,814 |
|
|
|
|
|
1,814 |
| |||
|
Current portion of long-term debt |
|
30,858 |
|
|
|
|
|
30,858 |
| |||
|
Current portion of finance obligation |
|
481 |
|
|
|
|
|
481 |
| |||
|
Other current liabilities |
|
6,484 |
|
|
|
|
|
6,484 |
| |||
|
Total current liabilities |
|
210,118 |
|
28,977 |
|
|
|
239,095 |
| |||
|
Long-term debt, less current portion |
|
1,009,196 |
|
|
|
|
|
1,009,196 |
| |||
|
Finance obligation, less current portion |
|
12,057 |
|
|
|
|
|
12,057 |
| |||
|
Embedded derivative & other financial instrument features of Series A convertible redeemable preferred stock |
|
23,541 |
|
3,798 |
|
B |
|
27,339 |
| |||
|
Other long-term liabilities |
|
39,861 |
|
|
|
|
|
39,861 |
| |||
|
Deferred income taxes |
|
3,716 |
|
|
|
|
|
3,716 |
| |||
|
Total liabilities |
|
1,298,489 |
|
32,775 |
|
|
|
1,331,264 |
| |||
|
|
|
|
|
|
|
|
|
|
| |||
|
Series A convertible redeemable preferred stock, $0.001 par value, $1,000 stated value, 3,500,000 authorized, 385,000 issued and outstanding at September 30, 2015 and December 31, 2014 |
|
404,179 |
|
(33,701 |
) |
C |
|
370,478 |
| |||
|
Noncontrolling interests - redeemable |
|
19,934 |
|
|
|
|
|
19,934 |
| |||
|
|
|
|
|
|
|
|
|
|
| |||
|
Commitments and Contingencies |
|
|
|
|
|
|
|
|
| |||
|
|
|
|
|
|
|
|
|
|
| |||
|
Equity: |
|
|
|
|
|
|
|
|
| |||
|
Common stock, $0.01 par value, 1,000,000 shares authorized 1,059 and 1,028 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively |
|
|
|
|
|
|
|
|
| |||
|
Additional paid-in capital |
|
569,036 |
|
30,697 |
|
D |
|
599,733 |
| |||
|
Retained deficit |
|
(1,174,400 |
) |
(29,771 |
) |
E |
|
(1,204,171 |
) | |||
|
Accumulated other comprehensive loss, net of tax |
|
(45,008 |
) |
|
|
|
|
(45,008 |
) | |||
|
Total 21st Century Oncology Holdings, Inc. shareholders deficit |
|
(650,372 |
) |
926 |
|
|
|
(649,446 |
) | |||
|
Noncontrolling interests - nonredeemable |
|
26,332 |
|
|
|
|
|
26,332 |
| |||
|
Total deficit |
|
(624,040 |
) |
926 |
|
|
|
(623,114 |
) | |||
|
Total liabilities and equity |
|
$ |
1,098,562 |
|
$ |
|
|
|
|
$ |
1,098,562 |
|
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1503518/000110465916096509/a15-18065_110q.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by 21St Century Oncology Holdings, Inc..
21St Century Oncology Holdings, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2016 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
21St Century Oncology Holdings, Inc. provided additional information to their SEC Filing as exhibits
Ticker: RTSX
CIK: 1503518
Form Type: 10-Q Quarterly Report
Accession Number: 0001104659-16-096509
Submitted to the SEC: Fri Feb 12 2016 2:31:52 PM EST
Accepted by the SEC: Fri Feb 12 2016
Period: Wednesday, September 30, 2015
Industry: Offices And Clinics Of Doctors Of Medicine